December 7, 2022

Testing whether a new drug impacts the progression of Parkinson’s disease takes years, in part because the disease often advances so slowly. Many Parkinson’s patients don’t have any worsening of their symptoms over the course of a typical clinical trial, even without treatment.

More...

Leave a Reply

Your email address will not be published. Required fields are marked *